An interventional study of Standard hypercaloric hyperproteic oral nutritional supplement and Leucine-enriched hypercaloric hyperproteic oral nutritional supplement in Sarcopenia and Cancer, sponsored by Maimónides Biomedical Research Institute of Córdoba. Completed at 1 site in Spain. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-05-09.
Sponsored by Maimónides Biomedical Research Institute of Córdoba · Not applicable, Interventional, and Supportive care
Currently there is a lack of evidence for recommending specific oral supplements (OS) for nutritional support in patients with cancer, including leucine-enriched supplements.
Appropriate clinical trials that compare anthropometric and biochemical changes in nutritional parameters and clinical outcomes in patients with cancer-induced sarcopenia are required
1,206 studies on the registry are indexed under Sarcopenia; 401 are open to participants now.
This study's enrollment of 48 is below the median of 60 across 773 interventional studies indexed under Sarcopenia.
Browse Sarcopenia studies →Maimónides Biomedical Research Institute of Córdoba is the lead sponsor of 78 studies on the registry; 20 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients will receive 2 supplements per day (Standard hypercaloric, hyperproteic oral supplement)
Dietary Supplement: Standard hypercaloric hyperproteic oral nutritional supplement
Patients will receive 2 supplements per day (Leucin-enriched hypercaloric, hyperproteic oral supplement)
Dietary Supplement: Leucine-enriched hypercaloric hyperproteic oral nutritional supplement
Patients will receive nutritional support with Standard hypercaloric hyperproteic oral nutritional supplement
Patients will receive nutritional support with Leucine-enriched hypercaloric hyperproteic oral nutritional supplement
Muscle mass gain
Changes in Muscle mass (%) determined by BIA and echography
Time frame: 3 Months
Fat mass change
Changes in fast mass (%) determined by BIA and echography
Time frame: 3 Months
Phase angle change
Changes in phase angle determined by BIA
Time frame: 3 Months
Changes in albumin
Changes in serum albumin levels (g/dL)
Time frame: 3 Months
Changes in prealbumin
Changes in serum prealbumin levels (mg/dL)
Time frame: 3 Months
Changes in CRP
Changes in serum CRP levels (g/L)
Time frame: 3 Months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Maimónides Biomedical Research Institute of Córdoba